Upload Avatar (500 x 500)
Zhiyong Wu
wzy2008@whu.edu.cn
Chinese, English
Hubei
Wuhan University
Medical School
  • 1996.09-2001.06 Bachelor of Clinical Medicine: Zhangjiakou Medical College
  • 2001.09-2004.06 Master of Surgery: Wuhan University First Clinical College
  • 2006.09-2011.12 PhD in Surgery: Wuhan University First Clinical College
  • Hosted and participated in multiple national and provincial research projects
  • Received 5 provincial and ministerial science and technology awards
  • 2004.07-2008.05 Wuhan University Renmin Hospital, Cardiovascular Surgery, Resident Physician
  • 2008.05-2016.11 Wuhan University Renmin Hospital, Cardiovascular Surgery, Attending Physician
  • 2014.03-2022.08 Wuhan University Renmin Hospital, Cardiovascular Surgery, Deputy Director
  • 2016.11-2020.11 Wuhan University Renmin Hospital, Cardiovascular Surgery, Associate Chief Physician
  • 2020.11-present Wuhan University Renmin Hospital, Cardiovascular Surgery, Chief Physician
  • 2022.08-present Wuhan University Renmin Hospital, Cardiovascular Surgery, Director
  • 2015 First Prize for Technological Progress in Hubei Province: Innovations in surgical techniques for complex ascending aortic dissection
  • 2019 Second Prize for Scientific and Technological Achievement Promotion in Hubei Province: Clinical promotion and application of innovative surgical techniques for complex ascending aortic dissection
Clinical and basic research of heart transplantation
Minimally invasive treatment of cardiovascular disease
  • Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients, Zhiyong Wu, Rui Hu, Cuizhen Zhang, Wei Ren, Anfeng Yu, Xiaoyang Zhou, 2020
  • Obesity is a risk factor for preoperative hypoxemia in Stanford A acute aortic dissection, Zhiyong Wu, Wang Z, Wu H, Hu R, Ren W, Hu Z, Chang J, 2020
  • A Novel Finding: Macrophages Involved in Inflammation Participate in Acute Aortic Dissection Complicated with Acute Lung Injury, Zhiyong Wu, Wang Z, Xu P, Zhang M, Cheng L, Gong B, 2017
  • Bindarit reduces the incidence of acute aortic dissection complicated lung injury through modulating NF-κB pathway, Zhiyong Wu, Chang J, Ren W, Hu Z, Li B, Liu H, 2017
  • Interleukin 22 attenuated angiotensin II induced acute ling injury through inhibiting the apoptosis of pulmonary microvascular endothelial cells, Zhiyong Wu, Hu Z, Cai X, Ren W, Dai F, Liu H, Chang J, Li B, 2017
  • VE-cadherin involved in the pulmonary microvascular endothelial cell barrier injury induced by angiotensin II through modulating the cellular apoptosis and skeletal rearrangement, Zhiyong Wu, Liu H, Ren W, Dai F, Chang J, Li B, 2016
  • Dephosphorylation of Y685–VE- cadherin involved in pulmonary microvascular endothelial barrier injury induced by angiotensin II, Zhiyong Wu, Wang Z, Dai F, Liu H, Ren W, Chang J, Li B, 2016
  • Angiotensin II is related to the acute aortic dissection complicated with lung injury through mediating the release of MMP9 from macrophages, Zhiyong Wu, Ruan Y, Chang J, Li B, Ren W, 2016
  • Angiotensin II induces apoptosis of human pulmonary microvascular endothelial cells in acute aortic dissection complicated with lung injury patients through modulating the expression of monocyte chemoattractant protein-1, Zhiyong Wu, Dai F, Ren W, Liu H, Li B, Chang J, 2016
  • Cyclic adenosine monophosphate protein kinase A signal pathway may be involved in pulmonary aquaporin-5 expression in ischemia/reperfusion rats following deep hypothermia cardiac arrest, Zhiyong Wu, Yao Y, Hu R, Dai FF, Zhang H, Mao ZF, 2016
  • Role of Nrf2 signal pathway in rats with deep hypothermia ischemia/reperfusion injury undergoing remote postconditioning, Zhiyong Wu, Wang ZW, Hu R, Zhou Z, Li LC, Mao ZF, 2015
Heart Transplantation Clinical Research Basic Research Cardiovascular Minimally Invasive Surgery Treatment Heart Disease Transplant Surgery Medical Innovation

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.